Review Article | ||||||||||||
IJMDC. 2020; 4(12): 2351-2356 Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review Ibrahim Mahmoud H. Ajwah, Wejdan Hlel Al-Atawi, Raghad Fraih A. Al-Balawi, Maram Atallah M. Albalawi, Abdulaziz Saed A. Albalawi, Rola Ali S. Alotabi, Sarah Fahad M. Bukhari, Amal Sulaiman A. Al-Balawi, Abdulaziz Saeed Alghamdi, Nouf Obaidullah M. Alenazi, Lama Akram A. Alanazi, Reham Hamid AlRuhil, Faisal Shiraz M. Alharthi, Sarah Muqbil B. Altmimi, Shahad Suliman H. Aljuhani, Raghad Saud A. Albalawi.
|
How to Cite this Article |
Pubmed Style Ajwah IMH, Al-Atawi WH, Al-Balawi RFA, Albalawi MAM, Albalawi ASA, Alotabi RAS, Bukhari SFM, Al-Balawi ASA, Alghamdi AS, Alenazi NOM, Alanazi LAA, AlRuhil RH, Alharthi FSM, Altmimi SMB, Aljuhani SSH, Albalawi RSA. Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. IJMDC. 2020; 4(12): 2351-2356. doi:10.24911/IJMDC.1-1602771830 Web Style Ajwah IMH, Al-Atawi WH, Al-Balawi RFA, Albalawi MAM, Albalawi ASA, Alotabi RAS, Bukhari SFM, Al-Balawi ASA, Alghamdi AS, Alenazi NOM, Alanazi LAA, AlRuhil RH, Alharthi FSM, Altmimi SMB, Aljuhani SSH, Albalawi RSA. Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. https://www.ijmdc.com/?mno=14192 [Access: May 09, 2024]. doi:10.24911/IJMDC.1-1602771830 AMA (American Medical Association) Style Ajwah IMH, Al-Atawi WH, Al-Balawi RFA, Albalawi MAM, Albalawi ASA, Alotabi RAS, Bukhari SFM, Al-Balawi ASA, Alghamdi AS, Alenazi NOM, Alanazi LAA, AlRuhil RH, Alharthi FSM, Altmimi SMB, Aljuhani SSH, Albalawi RSA. Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. IJMDC. 2020; 4(12): 2351-2356. doi:10.24911/IJMDC.1-1602771830 Vancouver/ICMJE Style Ajwah IMH, Al-Atawi WH, Al-Balawi RFA, Albalawi MAM, Albalawi ASA, Alotabi RAS, Bukhari SFM, Al-Balawi ASA, Alghamdi AS, Alenazi NOM, Alanazi LAA, AlRuhil RH, Alharthi FSM, Altmimi SMB, Aljuhani SSH, Albalawi RSA. Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. IJMDC. (2020), [cited May 09, 2024]; 4(12): 2351-2356. doi:10.24911/IJMDC.1-1602771830 Harvard Style Ajwah, I. M. H., Al-Atawi, . W. H., Al-Balawi, . R. F. A., Albalawi, . M. A. M., Albalawi, . A. S. A., Alotabi, . R. A. S., Bukhari, . S. F. M., Al-Balawi, . A. S. A., Alghamdi, . A. S., Alenazi, . N. O. M., Alanazi, . L. A. A., AlRuhil, . R. H., Alharthi, . F. S. M., Altmimi, . S. M. B., Aljuhani, . S. S. H. & Albalawi, . R. S. A. (2020) Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. IJMDC, 4 (12), 2351-2356. doi:10.24911/IJMDC.1-1602771830 Turabian Style Ajwah, Ibrahim Mahmoud H., Wejdan Hlel Al-Atawi, Raghad Fraih A. Al-Balawi, Maram Atallah M. Albalawi, Abdulaziz Saed A. Albalawi, Rola Ali S. Alotabi, Sarah Fahad M. Bukhari, Amal Sulaiman A. Al-Balawi, Abdulaziz Saeed Alghamdi, Nouf Obaidullah M. Alenazi, Lama Akram A. Alanazi, Reham Hamid AlRuhil, Faisal Shiraz M. Alharthi, Sarah Muqbil B. Altmimi, Shahad Suliman H. Aljuhani, and Raghad Saud A. Albalawi. 2020. Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. International Journal of Medicine in Developing Countries, 4 (12), 2351-2356. doi:10.24911/IJMDC.1-1602771830 Chicago Style Ajwah, Ibrahim Mahmoud H., Wejdan Hlel Al-Atawi, Raghad Fraih A. Al-Balawi, Maram Atallah M. Albalawi, Abdulaziz Saed A. Albalawi, Rola Ali S. Alotabi, Sarah Fahad M. Bukhari, Amal Sulaiman A. Al-Balawi, Abdulaziz Saeed Alghamdi, Nouf Obaidullah M. Alenazi, Lama Akram A. Alanazi, Reham Hamid AlRuhil, Faisal Shiraz M. Alharthi, Sarah Muqbil B. Altmimi, Shahad Suliman H. Aljuhani, and Raghad Saud A. Albalawi. "Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review." International Journal of Medicine in Developing Countries 4 (2020), 2351-2356. doi:10.24911/IJMDC.1-1602771830 MLA (The Modern Language Association) Style Ajwah, Ibrahim Mahmoud H., Wejdan Hlel Al-Atawi, Raghad Fraih A. Al-Balawi, Maram Atallah M. Albalawi, Abdulaziz Saed A. Albalawi, Rola Ali S. Alotabi, Sarah Fahad M. Bukhari, Amal Sulaiman A. Al-Balawi, Abdulaziz Saeed Alghamdi, Nouf Obaidullah M. Alenazi, Lama Akram A. Alanazi, Reham Hamid AlRuhil, Faisal Shiraz M. Alharthi, Sarah Muqbil B. Altmimi, Shahad Suliman H. Aljuhani, and Raghad Saud A. Albalawi. "Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review." International Journal of Medicine in Developing Countries 4.12 (2020), 2351-2356. Print. doi:10.24911/IJMDC.1-1602771830 APA (American Psychological Association) Style Ajwah, I. M. H., Al-Atawi, . W. H., Al-Balawi, . R. F. A., Albalawi, . M. A. M., Albalawi, . A. S. A., Alotabi, . R. A. S., Bukhari, . S. F. M., Al-Balawi, . A. S. A., Alghamdi, . A. S., Alenazi, . N. O. M., Alanazi, . L. A. A., AlRuhil, . R. H., Alharthi, . F. S. M., Altmimi, . S. M. B., Aljuhani, . S. S. H. & Albalawi, . R. S. A. (2020) Terlipressin versus norepinephrine in the treatment of type 1 hepatorenal syndrome: a review. International Journal of Medicine in Developing Countries, 4 (12), 2351-2356. doi:10.24911/IJMDC.1-1602771830 |